Conference item icon

Conference item

A randomised trial of conventional care versus radioablation (stereotactic body radiotherapy) for extracranial oligometastases

Abstract:

Studies indicate SBRT treatment of oligometastatic disease is associated with higher rates of local control with acceptably toxicity. A lack of randomised data in this area limits interpretation, preventing evaluation of the true benefit of adding SBRT to systemic therapy in this context. CORE investigates whether adding SBRT to standard therapy improves patient outcomes in common primary tumour sites where oligometastatic disease is encountered (NSCLC, breast and prostate). CORE aims to demo...

Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1016/j.clon.2018.02.061

Authors


More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Oncology
Sub department:
CRUK/MRC Ox Inst for Radiation Oncology
Role:
Author
ORCID:
0000-0002-6669-0628
Expand authors...
Publisher:
Elsevier Publisher's website
Journal:
Clinical Oncology Journal website
Volume:
30
Issue:
6
Pages:
e64-e64
Host title:
Clinical Oncology
Publication date:
2018-04-30
Acceptance date:
2018-02-09
DOI:
EISSN:
1433-2981
ISSN:
0936-6555
Source identifiers:
856254
Pubs id:
pubs:856254
UUID:
uuid:86613c8e-cfc3-46f1-a74b-d2f408324fd6
Local pid:
pubs:856254
Deposit date:
2018-10-30

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP